However, this benefit is completely lost in STING knockout mice, indicating that exogenous DNA or cGAMP can improve MS and EAE in a STING-dependent manner (Johnson et al, 2021; Mohamed et al, 2015). Here, STING1 is linked to myeloid sarcoma.